Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment
Identifieur interne : 005A67 ( Main/Exploration ); précédent : 005A66; suivant : 005A68Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment
Auteurs : Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; H. M. Shale [États-Unis] ; A. E. Lang [Canada] ; D. A. Chernik [États-Unis] ; T. A. Chmura [États-Unis] ; J. E. Ahlskog [États-Unis] ; E. E. Dorflinger [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1994.
English descriptors
- KwdEn :
- Activities of Daily Living (classification), Antiparkinson Agents (therapeutic use), Disability Evaluation, Dopamine Agents (therapeutic use), Dyskinesia, Humans, Movement Disorders (classification), Movement Disorders (diagnosis), Movement Disorders (drug therapy), Neurologic Examination (drug effects), Neurologic Examination (statistics & numerical data), Observer Variation, Parkinson Disease (classification), Parkinson Disease (diagnosis), Parkinson Disease (drug therapy), Parkinson's disease, Rating scale, Reproducibility of Results, Videotape Recording.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agents.
- classification : Activities of Daily Living, Movement Disorders, Parkinson Disease.
- diagnosis : Movement Disorders, Parkinson Disease.
- drug effects : Neurologic Examination.
- drug therapy : Movement Disorders, Parkinson Disease.
- statistics & numerical data : Neurologic Examination.
- Disability Evaluation, Humans, Observer Variation, Reproducibility of Results, Videotape Recording.
Abstract
Although dyskinesia is a frequent and important problem in Parkinson's disease (PD), a reliable assessment measure has not been thoroughly developed and tested. We modified the Obeso dyskinesia scale to creat an objective rating scale for dyskinesia assessment during activities of daily living. Thirteen physicians and 15 study coordinators involved in a clinical trial independently reviewed videotape segments of PD patients performing three tasks: walking, putting on a coat, and lifting a cup to the lips for drinking. Raters evaluated the severity of worst dyskinesia seen, the types of all dyskinesias seen, and the type of dyskinesia most associated with motoric disability. For all assessments, the total group showed statistically significant inter‐ and intrarater reliability. Physicians had a higher consistency than did coordinators, but for most measures the difference was not statistically significant. Physicians and coordinators found the scale easy to use and especially practical for rating dyskinesia severity and for identifying the most disabling dyskinesia. Dyskinesias can be assessed in clinical trials and warrant regular documentation.
Url:
DOI: 10.1002/mds.870090403
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002971
- to stream Istex, to step Curation: 002971
- to stream Istex, to step Checkpoint: 003E02
- to stream PubMed, to step Corpus: 004A88
- to stream PubMed, to step Curation: 004A88
- to stream PubMed, to step Checkpoint: 004A47
- to stream Ncbi, to step Merge: 004815
- to stream Ncbi, to step Curation: 004815
- to stream Ncbi, to step Checkpoint: 004815
- to stream Main, to step Merge: 008C58
- to stream Main, to step Curation: 005A67
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment</title><author><name sortKey="Goetz" sort="Goetz" uniqKey="Goetz" last="Goetz">Goetz</name></author><author><name sortKey="Stebbins, G T" sort="Stebbins, G T" uniqKey="Stebbins G" first="G. T." last="Stebbins">G. T. Stebbins</name></author><author><name sortKey="Shale, H M" sort="Shale, H M" uniqKey="Shale H" first="H. M." last="Shale">H. M. Shale</name></author><author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name></author><author><name sortKey="Chernik, D A" sort="Chernik, D A" uniqKey="Chernik D" first="D. A." last="Chernik">D. A. Chernik</name></author><author><name sortKey="Chmura, T A" sort="Chmura, T A" uniqKey="Chmura T" first="T. A." last="Chmura">T. A. Chmura</name></author><author><name sortKey="Ahlskog, J E" sort="Ahlskog, J E" uniqKey="Ahlskog J" first="J. E." last="Ahlskog">J. E. Ahlskog</name></author><author><name sortKey="Dorflinger, E E" sort="Dorflinger, E E" uniqKey="Dorflinger E" first="E. E." last="Dorflinger">E. E. Dorflinger</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3B68C7F20BCE69A49E231CBFF0527CEEAB1A1E08</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1002/mds.870090403</idno><idno type="url">https://api.istex.fr/document/3B68C7F20BCE69A49E231CBFF0527CEEAB1A1E08/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002971</idno><idno type="wicri:Area/Istex/Curation">002971</idno><idno type="wicri:Area/Istex/Checkpoint">003E02</idno><idno type="wicri:doubleKey">0885-3185:1994:Goetz:utility:of:an</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:7969204</idno><idno type="wicri:Area/PubMed/Corpus">004A88</idno><idno type="wicri:Area/PubMed/Curation">004A88</idno><idno type="wicri:Area/PubMed/Checkpoint">004A47</idno><idno type="wicri:Area/Ncbi/Merge">004815</idno><idno type="wicri:Area/Ncbi/Curation">004815</idno><idno type="wicri:Area/Ncbi/Checkpoint">004815</idno><idno type="wicri:doubleKey">0885-3185:1994:Goetz C:utility:of:an</idno><idno type="wicri:Area/Main/Merge">008C58</idno><idno type="wicri:Area/Main/Curation">005A67</idno><idno type="wicri:Area/Main/Exploration">005A67</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment</title><author><name sortKey="Goetz" sort="Goetz" uniqKey="Goetz" last="Goetz">Goetz</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Stebbins, G T" sort="Stebbins, G T" uniqKey="Stebbins G" first="G. T." last="Stebbins">G. T. Stebbins</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Shale, H M" sort="Shale, H M" uniqKey="Shale H" first="H. M." last="Shale">H. M. Shale</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hoffmann‐La Roche Inc., Nutley, New Jersey</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author><author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Morton and Gloria Shulman Movement Disorder Centre, The Toronto Hospital, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Chernik, D A" sort="Chernik, D A" uniqKey="Chernik D" first="D. A." last="Chernik">D. A. Chernik</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hoffmann‐La Roche Inc., Nutley, New Jersey</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author><author><name sortKey="Chmura, T A" sort="Chmura, T A" uniqKey="Chmura T" first="T. A." last="Chmura">T. A. Chmura</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Ahlskog, J E" sort="Ahlskog, J E" uniqKey="Ahlskog J" first="J. E." last="Ahlskog">J. E. Ahlskog</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Dorflinger, E E" sort="Dorflinger, E E" uniqKey="Dorflinger E" first="E. E." last="Dorflinger">E. E. Dorflinger</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Hoffmann‐La Roche Inc., Nutley, New Jersey</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1994">1994</date><biblScope unit="vol">9</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="390">390</biblScope><biblScope unit="page" to="394">394</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">3B68C7F20BCE69A49E231CBFF0527CEEAB1A1E08</idno><idno type="DOI">10.1002/mds.870090403</idno><idno type="ArticleID">MDS870090403</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activities of Daily Living (classification)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Disability Evaluation</term><term>Dopamine Agents (therapeutic use)</term><term>Dyskinesia</term><term>Humans</term><term>Movement Disorders (classification)</term><term>Movement Disorders (diagnosis)</term><term>Movement Disorders (drug therapy)</term><term>Neurologic Examination (drug effects)</term><term>Neurologic Examination (statistics & numerical data)</term><term>Observer Variation</term><term>Parkinson Disease (classification)</term><term>Parkinson Disease (diagnosis)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson's disease</term><term>Rating scale</term><term>Reproducibility of Results</term><term>Videotape Recording</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agents</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Activities of Daily Living</term><term>Movement Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Movement Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Movement Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Neurologic Examination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disability Evaluation</term><term>Humans</term><term>Observer Variation</term><term>Reproducibility of Results</term><term>Videotape Recording</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although dyskinesia is a frequent and important problem in Parkinson's disease (PD), a reliable assessment measure has not been thoroughly developed and tested. We modified the Obeso dyskinesia scale to creat an objective rating scale for dyskinesia assessment during activities of daily living. Thirteen physicians and 15 study coordinators involved in a clinical trial independently reviewed videotape segments of PD patients performing three tasks: walking, putting on a coat, and lifting a cup to the lips for drinking. Raters evaluated the severity of worst dyskinesia seen, the types of all dyskinesias seen, and the type of dyskinesia most associated with motoric disability. For all assessments, the total group showed statistically significant inter‐ and intrarater reliability. Physicians had a higher consistency than did coordinators, but for most measures the difference was not statistically significant. Physicians and coordinators found the scale easy to use and especially practical for rating dyskinesia severity and for identifying the most disabling dyskinesia. Dyskinesias can be assessed in clinical trials and warrant regular documentation.</div></front></TEI><affiliations><list><country><li>Canada</li><li>États-Unis</li></country><region><li>Illinois</li><li>Minnesota</li><li>New Jersey</li></region></list><tree><country name="États-Unis"><region name="Illinois"><name sortKey="Goetz" sort="Goetz" uniqKey="Goetz" last="Goetz">Goetz</name></region><name sortKey="Ahlskog, J E" sort="Ahlskog, J E" uniqKey="Ahlskog J" first="J. E." last="Ahlskog">J. E. Ahlskog</name><name sortKey="Chernik, D A" sort="Chernik, D A" uniqKey="Chernik D" first="D. A." last="Chernik">D. A. Chernik</name><name sortKey="Chmura, T A" sort="Chmura, T A" uniqKey="Chmura T" first="T. A." last="Chmura">T. A. Chmura</name><name sortKey="Dorflinger, E E" sort="Dorflinger, E E" uniqKey="Dorflinger E" first="E. E." last="Dorflinger">E. E. Dorflinger</name><name sortKey="Shale, H M" sort="Shale, H M" uniqKey="Shale H" first="H. M." last="Shale">H. M. Shale</name><name sortKey="Stebbins, G T" sort="Stebbins, G T" uniqKey="Stebbins G" first="G. T." last="Stebbins">G. T. Stebbins</name></country><country name="Canada"><noRegion><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A. E." last="Lang">A. E. Lang</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005A67 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005A67 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:3B68C7F20BCE69A49E231CBFF0527CEEAB1A1E08
|texte= Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment
}}
| This area was generated with Dilib version V0.6.23. |  |